458
Views
2
CrossRef citations to date
0
Altmetric
Review

Dobutamine stress echocardiography: a review and update

, , &
Pages 69-81 | Published online: 05 Apr 2014

References

  • Cheitlin MD. Stress echocardiography in mitral stenosis: When is it useful? J Am Coll Cardiol. 2004;43:402–404.
  • Pellikka PA, Nagueh SF, Elhendy AA, et al. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr. 2007;20:1021–1041.
  • Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol. 1993;21:1583–1590.
  • Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol. 1987;59:23C–30C.
  • Throckmorton DC. Approval package for application number NDA 17-820/S-037. Letter to Eli Lilly and Company, July 23, 2002. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/17-820_dobutrex_approv.pdf. Accessed October 28, 2013.
  • Picard MH, Adams D, Bierig SM, et al. American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr. 2011;24:1–10.
  • Ling LH, Pellikka PA, Mahoney DW, et al. Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting. J Am Coll Cardiol. 1996;28:551–557.
  • McNeill AJ, Fioretti PM, el-Said SM, Salustri A, Forster T, Roelandt JR. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol. 1992;70:41–46.
  • Fioretti PM, Poldermans D, Salustri A, et al. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J. 1994;15:355–360.
  • Karagiannis SE, Bax JJ, Elhendy A, et al. Enhanced sensitivity of dobutamine stress echocardiography by observing wall motion abnormalities during the recovery phase after acute beta-blocker administration. Am J Cardiol. 2006;97:462–465.
  • Mathias W, Tsutsui JM, Andrade JL, et al. Value of rapid beta-blocker injection at peak dobutamine-atropine stress echocardiography for detection of coronary artery disease. J Am Coll Cardiol. 2003;41:1583–1589.
  • Karagiannis SE, Feringa HH, Bax JJ, et al. Myocardial viability estimation during the recovery phase of stress echocardiography after acute beta-blocker administration. Eur J Heart Fail. 2007;9:403–408.
  • Shehata AR, Gillam LD, Mascitelli VA, et al. Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. Am J Cardiol. 1997;80:268–272.
  • Sicari R, Cortigiani L, Bigi R, et al; Echo-Dobutamine International Cooperative Study Group. Prognostic value of pharmacological stress echocardiography is affected by concomitant antiischemic therapy at the time of testing. Circulation. 2004;109:2428–2431.
  • Kane GC, Hepinstall MJ, Kidd GM, et al. Safety of stress echocardiography supervised by registered nurses: results of a 2-year audit of 15,404 patients. J Am Soc Echocardiogr. 2008;21:337–341.
  • Douglas PS, Garcia MJ, Haines DE, et al. 2011 appropriate use criteria for echocardiography. J Am Coll Cardiol. 2011;57:1126–1166.
  • Nakajima Y, Kane GC, McCully RB, Ommen SR, Pellikka PA. Left ventricular diastolic filling pressures during dobutamine stress echocardiography: relationship to symptoms and ischemia. J Am Soc Echocardiogr. 2009;22:947–953.
  • Ha JW, Oh JK, Pellikka PA, et al. Diastolic stress echocardiography: a novel noninvasive diagnostic test for diastolic dysfunction using supine bicycle exercise doppler echocardiography. J Am Soc Echocardiogr. 2005;18:63–68.
  • Pellikka PA, Roger VL, Oh JK, Seward JB, Tajik AJ. Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm > or =4 cm in diameter. Am J Cardiol. 1996;77:413–416.
  • Takhtehchian DS, Novaro GM, Barnett G, Griffin BP, Pellikka PA. Safety of dobutamine stress echocardiography in patients with unruptured intracranial aneurysms. J Am Soc Echocardiogr. 2002;15:1401–1404.
  • Geleijnse ML, Krenning BJ, van Dalen BM, et al. Factors affecting sensitivity and specificity of diagnostic testing: dobutamine stress echocardiography. J Am Soc Echocardiogr. 2009;22:1199–1208.
  • Wuthiwaropas P, Wiste JA, McCully RB, Kane GC, Scott CG, Pellikka PA. Neuropsychiatric symptoms during 24 hours after dobutamine-atropine stress testing: a prospective study in 1,006 patients. J Am Soc Echocardiogr. 2011;24:367–373.
  • Verani MS. Pharmacologic stress myocardial perfusion imaging. Curr Probl Cardiol. 1993;18:481–525.
  • Iskandrian AS, Verani MS, Heo J. Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease. J Nucl Cardiol. 1994;1:94–111.
  • Ryan T, Feigenbaum H. Exercise echocardiography. Am J Cardiol. 1992;69:82H–89H.
  • Kamaran M, Teague SM, Finkelhor RS, Dawson N, Bahler RC. Prognostic value of dobutamine stress echocardiography in patients referred because of suspected coronary artery disease. Am J Cardiol. 1995;76:887–891.
  • Ryan T, Segar DS, Sawada SG, et al. Detection of coronary artery disease with upright bicycle exercise echocardiography. J Am Soc Echocardiogr. 1993;6:186–197.
  • Hecht HS, DeBord L, Shaw R, et al. Digital supine bicycle stress echocardiography: A new technique for evaluating coronary artery disease. J Am Coll Cardiol. 1993;21:950–956.
  • Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med. 1999;130:719–728.
  • Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise spect imaging? A meta-analysis of diagnostic test performance. J Am Med Assoc. 1998;280:913–920.
  • Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol. 2007;49:227–237.
  • Shaw LJ, Vasey C, Sawada S, Rimmerman C, Marwick TH. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J. 2005;26:447–456.
  • Marwick T, D’Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: Combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol. 1993;22:159–167.
  • Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68:785–795.
  • Pigott JD, Kouchoukos NT, Oberman A, Cutter GR. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol. 1985;5:1036–1045.
  • Rees G, Bristow JD, Kremkau EL, et al. Influence of aortocoronary bypass surgery on left ventricular performance. New Engl J Med. 1971;284:1116–1120.
  • Chatterjee K, Swan HJ, Parmley WW, Sustaita H, Marcus HS, Matloff J. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation. 1973;47:276–286.
  • Brundage BH, Massie BM, Botvinick EH. Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol. 1984;3:902–908.
  • Cheirif J, Murgo JP. Assessment of myocardial viability by dobutamine echocardiography. Coron Artery Dis. 1995;6:600–605.
  • Cornel JH, Bax JJ, Elhendy A, et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: Implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol. 1998;31:1002–1010.
  • Gamici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation. 2008;117:103–114.
  • Meluzín J, Cerný J, Frélich M, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 1998;32:912–920.
  • Smart SC, Knickelbine T, Stoiber TR, Carlos M, Wynsen JC, Sagar KB. Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during the first week after acute myocardial infarction. Circulation. 1997;95:1394–1401.
  • Nijland F, Kamp O, Verhorst PM, de Voogt WG, Visser CA. In-hospital and long-term prognostic value of viable myocardium detected by dobutamine echocardiography early after acute myocardial infarction and its relation to indicators of left ventricular systolic dysfunction. Am J Cardiol. 2001;88:949–955.
  • Picano E, Sicari R, Landi P, et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation. 1998;98:1078–1084.
  • Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol. 1998;32:921–926.
  • Sawada SG, Lewis SJ, Foltz J, et al. Usefulness of rest and low-dose dobutamine wall motion scores in predicting survival and benefit from revascularization in patients with ischemic cardiomyopathy. Am J Cardiol. 2002;89:811–816.
  • Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91:663–670.
  • Ma L, Chen L, Gillam L, Waters DD, Chen C. Nitroglycerin enhances the ability of dobutamine stress echocardiography to detect hibernating myocardium. Circulation. 1997;96:3992–4001.
  • Pierard LA, Lancellotti P. Stress testing in valve disease. Heart. 2007;93:766–772.
  • Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused Update Incorporated into the ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease. Circulation. 2008;118:e523–e661.
  • Reis G, Motta MS, Barbosa MM, Esteves WA, Souza SF, Bocchi EA. Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosis. J Am Coll Cardiol. 2004;43:393–401.
  • deFilippi CR, Willett DL, Brickner ME, et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol. 1995;75:191–194.
  • Grayburn PA. Assessment of low-gradient aortic stenosis with dobutamine. Circulation. 2006;113:604–606.
  • Lin SS, Roger VL, Pascoe R, Seward JB, Pellikka PA. Dobutamine stress doppler hemodynamics in patients with aortic stenosis: feasibility, safety, and surgical correlations. Am Heart J. 1998;136:1010–1016.
  • Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1–23.
  • Monin JL, Quere JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108:319–324.
  • O’Connor K, Lancellotti P, Donal E, Pierard LA. Exercise echocardiography in severe asymptomatic aortic stenosis. Arch Cardiovasc Dis. 2010;103:262–269.
  • Zamorano JL, Badano LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur J Echocardiogr. 2011;12:557–584.
  • Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607.
  • Blais C, Burwash IG, Mundigler G, et al. Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (truly or pseudo-severe aortic stenosis) study. Circulation. 2006;113:711–721.
  • Himelman RB, Stulbarg MS, Lee E, Kuecherer HF, Schiller NB. Noninvasive evaluation of pulmonary artery systolic pressures during dynamic exercise by saline-enhanced doppler echocardiography. Am Heart J. 1990;119:685–688.
  • Hatle L, Angelsen BA, Tromsdal A. Non-invasive estimation of pulmonary artery systolic pressure with doppler ultrasound. Br Heart J. 1981;45:157–165.
  • Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70:657–662.
  • Himelman RB, Schiller NB. Exercise Doppler: functional evaluation of right heart dynamics. Echocardiography. 1992;9:225–233.
  • Kusunose K, Popovic ZB, Motoki H, Marwick TH. Prognostic significance of exercise-induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation. Circ Cardiovasc Imaging. 2013;6:167–176.
  • Lentine KL, Hurst FP, Jindal RM, et al. Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis. 2010;55:152–167.
  • Wang LW, Fahim MA, Hayen A, et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev. 2011;12:CD008691.
  • Bergeron S, Hillis GS, Haugen EN, Oh JK, Bailey KR, Pellikka PA. Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J. 2007;153:385–391.
  • Nguyen P, Plotkin J, Fishbein TM, et al. Dobutamine stress echocardiography in patients undergoing orthotopic liver transplantation: a pooled analysis of accuracy, perioperative and long term cardiovascular prognosis. Int J Cardiovasc Imaging. 2013;29:1741–1748.
  • Findlay JY, Keegan MT, Pellikka PP, Rosen CB, Plevak DJ. Preoperative dobutamine stress echocardiography, intraoperative events, and intraoperative myocardial injury in liver transplantation. Transplant Proc. 2005;37:2209–2213.
  • Harinstein ME, Flaherty JD, Ansari AH, et al. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant. 2008;8:1523–1528.
  • Heupler S, Mehta R, Lobo A, Leung D, Marwick TH. Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:414–420.
  • Marwick TH, Anderson T, Williams MJ, et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol. 1995;26:335–341.
  • Davar JI, Brull DJ, Bulugahipitiya S, Coghlan JG, Lipkin DP, Evans TR. Prognostic value of negative dobutamine stress echo in women with intermediate probability of coronary artery disease [Abstract]. Am J Cardiol. 1999;83(1):100–102, A8.
  • Ho YL, Wu CC, Huang PJ, et al. Assessment of coronary artery disease in women by dobutamine stress echocardiography: comparison with stress thallium-201 single-photon emission computed tomography and exercise electrocardiography. Am Heart J. 1998;135:655–662.
  • Cortigiani L, Picano E, Vigna C, et al. Prognostic value of pharmacologic stress echocardiography in patients with left bundle branch block. Am J Med. 2001;110:361–369.
  • Sicari R. Risk stratification by stress echocardiography beyond wall motion analysis. JACC Cardiovasc Imaging. 2009;2:260–262.
  • Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA Focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. Circulation. 2009;120:e169–e276.
  • Shan Y, Villarraga HR, Pislaru C, Shah AA, Cha SS, Pellikka PA. Quantitative assessment of strain and strain rate by velocity vector imaging during dobutamine stress echocardiography to predict outcome in patients with left bundle branch block. J Am Soc Echocardiogr. 2009;22:1212–1219.
  • Ha JW, Juracan EM, Mahoney DW, et al. Hypertensive response to exercise: a potential cause for new wall motion abnormality in the absence of coronary artery disease. J Am Coll Cardiol. 2002;39:323–327.
  • Lee CY, Pellikka PA, Shub C, Sinak LJ, Seward JB. Hypertensive response during dobutamine stress echocardiography. Am J Cardiol. 1997;80:970–971.
  • Nishioka T, Mitani H, Uehata A, et al. Utility and limitation of treadmill exercise echocardiography for detecting significant coronary stenosis in infarct-related arteries in patients with healed myocardial infarction. Am J Cardiol. 2002;89:159–163.
  • Mahajan N, Polavaram L, Vankayala H, et al. Diagnostic accuracy of myocardial perfusion imaging and stress echocardiography for the diagnosis of left main and triple vessel coronary artery disease: a comparative meta-analysis. Heart. 2010;96:956–966.
  • Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography. Eur J Echocardiogr. 2008;9:415–437.
  • Mastouri R, Sawada SG, Mahenthiran J. Current noninvasive imaging techniques for detection of coronary artery disease. Exp Rev Cardiovasc Ther. 2010;8:77–91.
  • Marwick TH. . Stress echocardiography with nonexercise techniques: principles, protocols, interpretation, and clinical applications. In: Otto C, editor. The Clinical Practice of Clinical Echocardiography. Philadelphia, PA, USA: Saunders Elsevier; 2007.
  • Makani H, Bangalore S, Halpern D, Makwana HG, Chaudhry FA. Cardiac outcomes with submaximal normal stress echocardiography: a meta-analysis. J Am Coll Cardiol. 2012;60:1393–1401.
  • Armstrong WF, Ryan T. Stress echocardiography from 1979 to present. J Am Soc Echocardiogr. 2008;21:22–28.
  • Steeds RP. Echocardiography: frontier imaging in cardiology. Br J Radiol. 2011;84 Spec No 3:S237–S245.
  • Cullen MW, Pellikka PA. Recent advances in stress echocardiography. Curr Opin Cardiol. 2011;26:379–384.
  • Ng AC, Sitges M, Pham PN, et al. Incremental value of 2-dimensional speckle tracking strain imaging to wall motion analysis for detection of coronary artery disease in patients undergoing dobutamine stress echocardiography. Am Heart J. 2009;158:836–844.
  • Geleijnse ML, Krenning BJ, Nemes A, et al. Incidence, pathophysiology, and treatment of complications during dobutamine-atropine stress echocardiography. Circulation. 2010;121:1756–1767.